The Board meeting approved the Unaudited financial results of the Company for the quarter and nine months ended 31.12.2025 together with Limited Review Report. The Unaudited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.9 pts less than Nifty Microcap 250 and 2.2 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board approved unaudited financial results for Q3 and nine months ended December 31, 2025, along with a clean (unqualified) limited review report from auditors. Revenue from operations slipped to Rs 6,161.85 lakhs in Q3 FY26 from Rs 6,454.52 lakhs a year ago, and fell about 16.4% to Rs 20,164.54 lakhs for the nine-month period (from Rs 24,128.83 lakhs). Profit after tax dropped sharply to Rs 298.31 lakhs for Q3 (from Rs 502.49 lakhs) and to Rs 919.85 lakhs for nine months (from Rs 1,803.73 lakhs), roughly a 49% decline. EPS for nine months stood at Rs 11.75 versus Rs 23.04 previously. Separately, a new KSIDC nominee director could not be appointed as the candidate declined to give consent, and the Stakeholder Relationship Committee was reconstituted with three members.
Double-digit declines in both revenue (~16% for 9M) and profit (~49% for 9M) signal clear operational weakness, which is likely to weigh negatively on the stock. The unresolved KSIDC board vacancy is procedural and not material to operations.